This was reported by RIA Novosti with reference to a statement by the press secretary of the institute, Clara Brunzlikova.
“The experts of our institute started working on Sputnik V, but, unfortunately, we have very little relevant information, based on which one could come to any conclusions,” she said.
Bruntslikova clarified that the study is being carried out in accordance with the instructions of the apparatus of the Cabinet of Ministers of the Czech Republic.
Earlier, Czech Prime Minister Andrei Babis expressed the opinion that the Czech Republic could begin vaccination with the Russian drug against the coronavirus Sputnik V without registering it with the European Medicines Agency (EMA).